Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and...

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Oncology

Background:

• Bufadienolides are a class of natural compounds with potential therapeutic applications.
• Understanding their structure-activity relationships is crucial for developing new anticancer agents.
• Cancer cell line models are essential for evaluating drug efficacy.

Purpose of the Study:

• To evaluate the in vitro growth inhibitory effects of bufadienolides and their degradation products on various cancer cell lines.
• To identify key structural features of bufadienolides responsible for their anticancer activity.
• To compare the efficacy of bufadienolides with established cardenolides like ouabain and digoxin.

Main Methods:

• An MTT colorimetric assay was used to assess the in vitro growth inhibitory effects.
• Twenty-seven bufadienolides and eight degradation products were tested.
• Six human and two mouse cancer cell lines were utilized for the study.

Main Results:

• Several bufadienolides, including gamabufotalin rhamnoside (1a), bufotalin (2a), and hellebrin (3a), demonstrated superior growth inhibition in human cancer cell lines compared to ouabain and digoxin.
• Gamabufotalin rhamnoside (1a) exhibited significant growth inhibition (<1 μM) in mouse cancer cells with mutated Na(+),K(+)-ATPase α-1 subunits.
• Genins and degradation products generally showed weaker activity than their glycosylated counterparts, with hellebrigenin (3b) being a notable exception.

Conclusions:

• Bufadienolides represent a promising class of compounds for cancer therapy.
• Specific bufadienolides possess potent in vitro anticancer activity, warranting further investigation.
• Structure-activity relationship analysis highlights the importance of glycosylation for bufadienolide efficacy.